| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF729 ZNF726P1 RLF ZBTB10 ZNF521 ZNF737 ZNF808 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF684 ZNF678 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 2.48e-18 | 1412 | 43 | 25 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF729 ZNF726P1 ZBTB10 ZNF521 ZNF737 ZNF808 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF684 ZNF678 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 9.24e-17 | 1459 | 43 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF729 ZNF726P1 ZNF521 ZNF737 ZNF808 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF678 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 7.49e-16 | 1244 | 43 | 22 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF729 ZNF726P1 ZNF521 ZNF737 ZNF808 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF678 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 1.17e-15 | 1271 | 43 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | ZNF729 ZBTB10 SP2 ZNF134 KLF12 ZNF217 ZEB1 ZNF99 ZEB2 ZNF572 | 1.17e-09 | 320 | 43 | 10 | GO:0001227 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | ZNF729 ZBTB10 SP2 ZNF134 KLF12 ZNF217 ZEB1 ZNF99 ZEB2 ZNF572 | 1.39e-09 | 326 | 43 | 10 | GO:0001217 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.76e-04 | 560 | 43 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.88e-04 | 566 | 43 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | snoRNA binding | 2.43e-03 | 34 | 43 | 2 | GO:0030515 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZNF729 ZBTB10 SP2 ZNF134 KLF12 ZNF217 ZBTB38 ZEB1 RESF1 ZNF99 ZEB2 ZNF423 ZNF572 | 1.99e-06 | 1413 | 41 | 13 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZNF729 ZBTB10 SP2 ZNF134 KLF12 ZNF217 ZBTB38 ZEB1 ZNF99 ZEB2 ZNF423 ZNF572 | 1.13e-05 | 1399 | 41 | 12 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | ZNF729 ZBTB10 SP2 ZNF134 KLF12 ZNF217 ZEB1 ZNF99 ZEB2 ZNF572 | 3.03e-05 | 1053 | 41 | 10 | GO:0000122 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF729 RLF ZNF521 ZNF808 KLF12 ZBTB38 ZNF143 ZEB1 ZNF99 CDK12 ZEB2 | 6.02e-05 | 1390 | 41 | 11 | GO:0045944 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF729 RLF ZBTB10 ZNF521 ZNF737 ZNF808 BNC2 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF684 ZNF678 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 2.52e-24 | 775 | 42 | 25 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF729 RLF ZBTB10 ZNF521 ZNF737 ZNF808 BNC2 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF684 ZNF678 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 2.69e-24 | 777 | 42 | 25 | PS00028 |
| Domain | Znf_C2H2 | ZNF729 RLF ZBTB10 ZNF521 ZNF737 ZNF808 BNC2 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF684 ZNF678 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 6.44e-24 | 805 | 42 | 25 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF729 RLF ZBTB10 ZNF521 ZNF737 ZNF808 BNC2 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF684 ZNF678 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 7.05e-24 | 808 | 42 | 25 | SM00355 |
| Domain | - | ZNF729 RLF ZBTB10 ZNF521 ZNF737 ZNF808 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF684 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 1.27e-22 | 679 | 42 | 23 | 3.30.160.60 |
| Domain | Znf_C2H2-like | ZNF729 RLF ZBTB10 ZNF521 ZNF737 ZNF808 BNC2 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF684 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 1.57e-22 | 796 | 42 | 24 | IPR015880 |
| Domain | zf-C2H2 | ZNF729 RLF ZBTB10 ZNF521 ZNF737 ZNF808 BNC2 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZNF90 ZNF99 ZNF684 ZNF678 ZNF257 ZNF423 ZNF572 ZNF114 | 2.01e-22 | 693 | 42 | 23 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF729 RLF ZBTB10 ZNF521 ZNF737 ZNF808 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF684 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 2.08e-22 | 694 | 42 | 23 | IPR013087 |
| Domain | zf-C2H2_6 | ZNF729 ZNF521 ZNF737 ZNF808 ZNF880 ZNF90 ZNF99 ZNF684 ZNF423 ZNF572 ZNF114 | 6.86e-11 | 314 | 42 | 11 | PF13912 |
| Domain | KRAB | ZNF729 ZNF737 ZNF808 ZNF880 ZNF90 ZNF99 ZNF684 ZNF257 ZNF114 | 8.06e-08 | 358 | 42 | 9 | PS50805 |
| Domain | KRAB | ZNF729 ZNF737 ZNF808 ZNF880 ZNF90 ZNF99 ZNF684 ZNF257 ZNF114 | 8.06e-08 | 358 | 42 | 9 | PF01352 |
| Domain | KRAB | ZNF729 ZNF737 ZNF808 ZNF880 ZNF90 ZNF99 ZNF684 ZNF257 ZNF114 | 1.04e-07 | 369 | 42 | 9 | SM00349 |
| Domain | KRAB | ZNF729 ZNF737 ZNF808 ZNF880 ZNF90 ZNF99 ZNF684 ZNF257 ZNF114 | 1.07e-07 | 370 | 42 | 9 | IPR001909 |
| Domain | Di19_Zn_binding_dom | 1.03e-04 | 7 | 42 | 2 | IPR008598 | |
| Domain | zf-Di19 | 1.03e-04 | 7 | 42 | 2 | PF05605 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF729 ZNF521 ZNF737 ZNF740 ZNF143 ZNF99 ZNF684 ZNF678 ZNF257 CDK12 CNOT3 ZNF114 | 8.28e-06 | 1387 | 29 | 12 | M734 |
| Pathway | REACTOME_FORMATION_OF_THE_POSTERIOR_NEURAL_PLATE | 1.82e-04 | 10 | 29 | 2 | M48036 | |
| Pathway | REACTOME_FORMATION_OF_THE_ANTERIOR_NEURAL_PLATE | 2.22e-04 | 11 | 29 | 2 | M48031 | |
| Pathway | REACTOME_RRNA_PROCESSING | 7.76e-04 | 205 | 29 | 4 | M27685 | |
| Pubmed | MRPS15 RLF ZBTB10 ZNF521 SP2 KLF12 ZNF217 ZNF143 ZEB1 RESF1 PGAM5 ZEB2 CNOT3 GNL3 BMS1 | 7.65e-11 | 1429 | 43 | 15 | 35140242 | |
| Pubmed | 3.65e-09 | 16 | 43 | 4 | 8467795 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.37e-07 | 351 | 43 | 7 | 38297188 | |
| Pubmed | 5.24e-07 | 808 | 43 | 9 | 20412781 | ||
| Pubmed | Investigation of primary microcephaly in Bushehr province of Iran: novel STIL and ASPM mutations. | 1.49e-06 | 2 | 43 | 2 | 22989186 | |
| Pubmed | The Zeb proteins δEF1 and Sip1 may have distinct functions in lens cells following cataract surgery. | 1.49e-06 | 2 | 43 | 2 | 25082886 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 37948583 | ||
| Pubmed | ZEBs: Novel Players in Immune Cell Development and Function. | 1.49e-06 | 2 | 43 | 2 | 30956067 | |
| Pubmed | The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2. | 1.49e-06 | 2 | 43 | 2 | 37819755 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 28416756 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 28133913 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 20025777 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 20424117 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 12609600 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24306957 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 12393497 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 20375168 | ||
| Pubmed | Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma. | 1.49e-06 | 2 | 43 | 2 | 29476046 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 22213144 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 21747944 | ||
| Pubmed | Functional conservation of zinc-finger homeodomain gene zfh1/SIP1 in Drosophila heart development. | 1.49e-06 | 2 | 43 | 2 | 16957952 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 29516288 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 34550965 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 22892238 | ||
| Pubmed | 2.96e-06 | 181 | 43 | 5 | 37372979 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 26823172 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 23412770 | ||
| Pubmed | A miRNA signature associated with human metastatic medullary thyroid carcinoma. | 4.48e-06 | 3 | 43 | 2 | 24127332 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 21890822 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 18376396 | ||
| Pubmed | TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression. | 4.48e-06 | 3 | 43 | 2 | 31933004 | |
| Pubmed | p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. | 4.48e-06 | 3 | 43 | 2 | 21518799 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 18411277 | ||
| Pubmed | miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. | 4.48e-06 | 3 | 43 | 2 | 25833697 | |
| Pubmed | Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2. | 4.48e-06 | 3 | 43 | 2 | 24968735 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 29052277 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 24891617 | ||
| Pubmed | Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran. | 4.48e-06 | 3 | 43 | 2 | 31244281 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 34226299 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 26022123 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 21411626 | ||
| Pubmed | BMP4 signaling mediates Zeb family in developing mouse tooth. | 4.48e-06 | 3 | 43 | 2 | 22350174 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 24615544 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 17615296 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 24165969 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 26556542 | ||
| Pubmed | ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. | 4.48e-06 | 3 | 43 | 2 | 26788497 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 29302045 | ||
| Pubmed | Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. | 8.94e-06 | 4 | 43 | 2 | 25301070 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 28247944 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 16598713 | ||
| Pubmed | miR-200b regulates cell migration via Zeb family during mouse palate development. | 8.94e-06 | 4 | 43 | 2 | 22261924 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 31679088 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 17360662 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 29200203 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 21079000 | ||
| Pubmed | The MicroRNA 29 Family Promotes Type II Cell Differentiation in Developing Lung. | 8.94e-06 | 4 | 43 | 2 | 27215389 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 23381389 | ||
| Pubmed | 1.22e-05 | 418 | 43 | 6 | 34709266 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 18829540 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 14630787 | ||
| Pubmed | ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates. | 1.49e-05 | 5 | 43 | 2 | 29449309 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 12743039 | ||
| Pubmed | Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. | 1.49e-05 | 5 | 43 | 2 | 12743038 | |
| Pubmed | A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. | 1.49e-05 | 5 | 43 | 2 | 19651985 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 22685266 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 12161443 | ||
| Pubmed | A Zeb2-miR-200c loop controls midbrain dopaminergic neuron neurogenesis and migration. | 4.16e-05 | 8 | 43 | 2 | 30271956 | |
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 16061479 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 19754958 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 25460509 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 12714599 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.71e-05 | 1082 | 43 | 8 | 38697112 | |
| Pubmed | Location of the 9257 and ataxia mutations on mouse chromosome 18. | 5.35e-05 | 9 | 43 | 2 | 8662222 | |
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 24769727 | ||
| Pubmed | 5.74e-05 | 335 | 43 | 5 | 15741177 | ||
| Pubmed | Functional analysis of the SRY-KRAB interaction in mouse sex determination. | 6.68e-05 | 10 | 43 | 2 | 18588511 | |
| Pubmed | Maternal diabetes induces senescence and neural tube defects sensitive to the senomorphic rapamycin. | 6.68e-05 | 10 | 43 | 2 | 34193422 | |
| Pubmed | Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. | 8.15e-05 | 11 | 43 | 2 | 15469996 | |
| Pubmed | 9.78e-05 | 12 | 43 | 2 | 17967884 | ||
| Pubmed | 1.15e-04 | 13 | 43 | 2 | 19850934 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.29e-04 | 398 | 43 | 5 | 35016035 | |
| Pubmed | Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis. | 1.35e-04 | 14 | 43 | 2 | 26324903 | |
| Pubmed | 1.55e-04 | 15 | 43 | 2 | 15885501 | ||
| Pubmed | 1.55e-04 | 15 | 43 | 2 | 33158935 | ||
| Pubmed | 1.60e-04 | 417 | 43 | 5 | 36537216 | ||
| Pubmed | 1.73e-04 | 971 | 43 | 7 | 33306668 | ||
| Pubmed | 1.77e-04 | 16 | 43 | 2 | 36418889 | ||
| Pubmed | Zfp423/OAZ participates in a developmental switch during olfactory neurogenesis. | 1.77e-04 | 16 | 43 | 2 | 17521568 | |
| Pubmed | 1.77e-04 | 16 | 43 | 2 | 25942625 | ||
| Pubmed | 1.77e-04 | 16 | 43 | 2 | 20301772 | ||
| Pubmed | 2.01e-04 | 17 | 43 | 2 | 31171776 | ||
| Pubmed | 2.01e-04 | 17 | 43 | 2 | 7557990 | ||
| Pubmed | PDGFRα controls the balance of stromal and adipogenic cells during adipose tissue organogenesis. | 2.52e-04 | 19 | 43 | 2 | 28049691 | |
| Pubmed | 2.80e-04 | 20 | 43 | 2 | 20846217 | ||
| Pubmed | Loss of Sip1 leads to migration defects and retention of ectodermal markers during lens development. | 3.09e-04 | 21 | 43 | 2 | 24161570 | |
| Pubmed | Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease. | 3.09e-04 | 21 | 43 | 2 | 27591083 | |
| Pubmed | Genome-wide association analysis identifies 20 loci that influence adult height. | 3.40e-04 | 22 | 43 | 2 | 18391952 | |
| Pubmed | 4.03e-04 | 1116 | 43 | 7 | 31753913 | ||
| Pubmed | 4.05e-04 | 116 | 43 | 3 | 30804394 | ||
| Interaction | FEV interactions | 8.12e-09 | 203 | 42 | 8 | int:FEV | |
| Interaction | NFIX interactions | 4.05e-07 | 227 | 42 | 7 | int:NFIX | |
| Interaction | KLF16 interactions | 2.31e-06 | 425 | 42 | 8 | int:KLF16 | |
| Interaction | KLF12 interactions | 2.90e-06 | 194 | 42 | 6 | int:KLF12 | |
| Interaction | MBD3L2 interactions | 8.49e-05 | 41 | 42 | 3 | int:MBD3L2 | |
| Interaction | KLF3 interactions | 1.07e-04 | 228 | 42 | 5 | int:KLF3 | |
| Interaction | ELK3 interactions | 1.12e-04 | 120 | 42 | 4 | int:ELK3 | |
| Interaction | MYB interactions | 1.67e-04 | 133 | 42 | 4 | int:MYB | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 1.08e-07 | 122 | 43 | 5 | chr19p12 | |
| Cytoband | 19p12 | 1.61e-06 | 90 | 43 | 4 | 19p12 | |
| Cytoband | 1p32 | 2.96e-04 | 27 | 43 | 2 | 1p32 | |
| Cytoband | 19q13.41 | 2.46e-03 | 78 | 43 | 2 | 19q13.41 | |
| Cytoband | 19q13.4 | 2.52e-03 | 79 | 43 | 2 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 2.65e-03 | 294 | 43 | 3 | chr1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.97e-03 | 1192 | 43 | 5 | chr19q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF729 RLF ZBTB10 ZNF521 ZNF737 ZNF808 BNC2 SP2 ZNF134 ZNF740 KLF12 ZNF880 ZNF217 ZBTB38 ZNF143 ZEB1 ZNF90 ZNF99 ZNF684 ZNF678 ZNF257 ZEB2 ZNF423 ZNF572 ZNF114 | 1.62e-29 | 718 | 32 | 25 | 28 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.14e-04 | 15 | 32 | 2 | 529 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 2.34e-02 | 134 | 32 | 2 | 861 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 1.30e-05 | 404 | 42 | 7 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 3.12e-05 | 91 | 42 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.22e-04 | 397 | 42 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.36e-04 | 790 | 42 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.38e-04 | 406 | 42 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 1.47e-04 | 799 | 42 | 8 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.50e-04 | 801 | 42 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.51e-04 | 413 | 42 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| ToppCell | Leuk-UTI-Myeloid-tDC|Leuk-UTI / Disease, Lineage and Cell Type | 1.59e-05 | 161 | 42 | 4 | 51b9f60986ed2e8e2297d31c80462c3ab65a2e5e | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 165 | 42 | 4 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-05 | 170 | 42 | 4 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-05 | 170 | 42 | 4 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 182 | 42 | 4 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.86e-05 | 187 | 42 | 4 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-05 | 187 | 42 | 4 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.98e-05 | 189 | 42 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.04e-05 | 190 | 42 | 4 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | CV-Moderate-0|Moderate / Virus stimulation, Condition and Cluster | 3.10e-05 | 191 | 42 | 4 | 6776bcc4c1915f0c1062002ff7746f20ceb725f4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-05 | 191 | 42 | 4 | b6cc0a9ced40ce5f80065d24d5bc20e3838a7682 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.17e-05 | 192 | 42 | 4 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 3.17e-05 | 192 | 42 | 4 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-tDC|Leuk-UTI / Disease, condition lineage and cell class | 3.64e-05 | 199 | 42 | 4 | a2f154b15087803958a656d2a41b6d83fd37b32f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-05 | 200 | 42 | 4 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-05 | 200 | 42 | 4 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-05 | 200 | 42 | 4 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-05 | 200 | 42 | 4 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | PBMC-Severe-cDC_2|Severe / Compartment, Disease Groups and Clusters | 3.80e-05 | 69 | 42 | 3 | 0fab02d29408415d3aa1f42a55a2e37b458c4030 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-04 | 136 | 42 | 3 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-04 | 136 | 42 | 3 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| ToppCell | Dividing_Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.94e-04 | 152 | 42 | 3 | e39cfc346b35235546b303e7d73e4d9d7120a5fb | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 3.94e-04 | 152 | 42 | 3 | f944743f40ff6ed3a7a096dd53e12d3526c67c4d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-04 | 156 | 42 | 3 | f894fac4e44a23718b20ad80c9677bf4f2118002 | |
| ToppCell | COVID-19-APC-like-Alveolar_macrophages|COVID-19 / group, cell type (main and fine annotations) | 4.25e-04 | 156 | 42 | 3 | 735ade77cfa16b9386a0c7ec2bd14bd2e78a51ad | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.49e-04 | 159 | 42 | 3 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.58e-04 | 160 | 42 | 3 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.66e-04 | 161 | 42 | 3 | c61283c301a87bb802f6f8ce79c26067032dd7d9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.66e-04 | 161 | 42 | 3 | 9864d8b0929dacf4be7a4e97d2527ac3120ea264 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.75e-04 | 162 | 42 | 3 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-04 | 163 | 42 | 3 | 73c03e29a6d7a6863c5e9aa5e8b963ef691f1ddb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-04 | 165 | 42 | 3 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.09e-04 | 166 | 42 | 3 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.27e-04 | 168 | 42 | 3 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 5.27e-04 | 168 | 42 | 3 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 5.37e-04 | 169 | 42 | 3 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 5.37e-04 | 169 | 42 | 3 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-04 | 169 | 42 | 3 | 02fa66a91b8bd2bf971aec4f5ec58318b5bfdf14 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-04 | 169 | 42 | 3 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 5.37e-04 | 169 | 42 | 3 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 5.46e-04 | 170 | 42 | 3 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-04 | 171 | 42 | 3 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-04 | 171 | 42 | 3 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 5.65e-04 | 172 | 42 | 3 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 5.65e-04 | 172 | 42 | 3 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.74e-04 | 173 | 42 | 3 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-04 | 174 | 42 | 3 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-04 | 174 | 42 | 3 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 5.84e-04 | 174 | 42 | 3 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 5.94e-04 | 175 | 42 | 3 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-04 | 176 | 42 | 3 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.04e-04 | 176 | 42 | 3 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 6.04e-04 | 176 | 42 | 3 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-04 | 177 | 42 | 3 | 1921226196b2ab7919d9f843e60d9f4bd9ec9c57 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 6.24e-04 | 178 | 42 | 3 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-04 | 179 | 42 | 3 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-04 | 180 | 42 | 3 | 271ee52ed8f21f78ddf68e52fc88fe582701675e | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.45e-04 | 180 | 42 | 3 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.76e-04 | 183 | 42 | 3 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 6.76e-04 | 183 | 42 | 3 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.76e-04 | 183 | 42 | 3 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-04 | 184 | 42 | 3 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-04 | 184 | 42 | 3 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.87e-04 | 184 | 42 | 3 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.87e-04 | 184 | 42 | 3 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.98e-04 | 185 | 42 | 3 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.98e-04 | 185 | 42 | 3 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.98e-04 | 185 | 42 | 3 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.98e-04 | 185 | 42 | 3 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.98e-04 | 185 | 42 | 3 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | Control-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 7.09e-04 | 186 | 42 | 3 | e9e58c5871b4966cd3586b611703e21af8df6360 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 186 | 42 | 3 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 186 | 42 | 3 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.09e-04 | 186 | 42 | 3 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.20e-04 | 187 | 42 | 3 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.20e-04 | 187 | 42 | 3 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-Cycling_NK|GI_small-bowel / Manually curated celltypes from each tissue | 7.20e-04 | 187 | 42 | 3 | 265c690c2921fd201361a0ec8bc4d2a996fbcaf4 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.20e-04 | 187 | 42 | 3 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 7.20e-04 | 187 | 42 | 3 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.20e-04 | 187 | 42 | 3 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.31e-04 | 188 | 42 | 3 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 7.31e-04 | 188 | 42 | 3 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 7.31e-04 | 188 | 42 | 3 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.42e-04 | 189 | 42 | 3 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 7.42e-04 | 189 | 42 | 3 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 7.42e-04 | 189 | 42 | 3 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | IPF-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 7.42e-04 | 189 | 42 | 3 | 49e67d298d045f29136919b7d9971b6502b0efaa | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.42e-04 | 189 | 42 | 3 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_gd|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.54e-04 | 190 | 42 | 3 | 268772d2adff34f7175b8474e95b67fd96dc1234 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 7.54e-04 | 190 | 42 | 3 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.54e-04 | 190 | 42 | 3 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.54e-04 | 190 | 42 | 3 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.54e-04 | 190 | 42 | 3 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 7.65e-04 | 191 | 42 | 3 | db7b8f8826bf19d6eeee14319570a9e6e99ab2cb | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.65e-04 | 191 | 42 | 3 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.65e-04 | 191 | 42 | 3 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.65e-04 | 191 | 42 | 3 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 7.65e-04 | 191 | 42 | 3 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.65e-04 | 191 | 42 | 3 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.65e-04 | 191 | 42 | 3 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 1.29e-04 | 12 | 42 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | body fat distribution | 1.95e-04 | 202 | 42 | 4 | EFO_0004341 | |
| Disease | Autosomal recessive primary microcephaly | 2.05e-04 | 15 | 42 | 2 | cv:C3711387 | |
| Disease | Primary microcephaly | 4.49e-04 | 22 | 42 | 2 | C0431350 | |
| Disease | Autosomal Recessive Primary Microcephaly | 4.49e-04 | 22 | 42 | 2 | C3711387 | |
| Disease | ovarian neoplasm | 9.24e-04 | 134 | 42 | 3 | C0919267 | |
| Disease | microcephaly (implicated_via_orthology) | 9.55e-04 | 32 | 42 | 2 | DOID:10907 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of ovary | 9.85e-04 | 137 | 42 | 3 | C1140680 | |
| Disease | hair color | 9.88e-04 | 311 | 42 | 4 | EFO_0003924 | |
| Disease | cutaneous squamous cell carcinoma | 1.02e-03 | 33 | 42 | 2 | EFO_1001927 | |
| Disease | cannabis dependence measurement | 2.14e-03 | 48 | 42 | 2 | EFO_0008457 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.60e-03 | 53 | 42 | 2 | C1961099 | |
| Disease | susceptibility to common cold measurement | 2.70e-03 | 54 | 42 | 2 | EFO_0008417 | |
| Disease | colorectal health | 2.94e-03 | 201 | 42 | 3 | EFO_0008460 | |
| Disease | mean platelet volume | 3.04e-03 | 1020 | 42 | 6 | EFO_0004584 | |
| Disease | Familial Nonmedullary Thyroid Cancer | 3.43e-03 | 61 | 42 | 2 | C3501844 | |
| Disease | Nonmedullary Thyroid Carcinoma | 3.43e-03 | 61 | 42 | 2 | C3501843 | |
| Disease | Eczema, allergic rhinitis | 3.55e-03 | 215 | 42 | 3 | EFO_0005854, HP_0000964 | |
| Disease | Testicular Germ Cell Tumor | 4.88e-03 | 73 | 42 | 2 | EFO_1000566 | |
| Disease | skin neoplasm | 5.01e-03 | 74 | 42 | 2 | EFO_0004198 | |
| Disease | balding measurement | 5.15e-03 | 792 | 42 | 5 | EFO_0007825 | |
| Disease | sudden cardiac arrest | 6.26e-03 | 83 | 42 | 2 | EFO_0004278 | |
| Disease | Papillary thyroid carcinoma | 6.70e-03 | 86 | 42 | 2 | C0238463 | |
| Disease | physical activity | 7.01e-03 | 88 | 42 | 2 | EFO_0003940 | |
| Disease | Uterine leiomyoma | 7.48e-03 | 91 | 42 | 2 | HP_0000131 | |
| Disease | red blood cell density measurement | 7.96e-03 | 880 | 42 | 5 | EFO_0007978 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HRLVSKHKRHKSKHS | 36 | Q9NYV4 | |
| LKIHYNAVHLKIKHR | 456 | Q6ZN30 | |
| SFHRTQDLKTKKHHI | 56 | Q14692 | |
| LIQRKYRAHLCTKHH | 2291 | Q8IZT6 | |
| IEGLKRHIEKHRYHV | 166 | O75175 | |
| ASLHAHSRKKVKRKH | 166 | Q9UGY1 | |
| HHVYKKTDHRNVELT | 231 | Q96G21 | |
| HYKAKATRHIFLIRH | 91 | Q96HS1 | |
| HRKIYTKKHHSQTSL | 321 | Q8NFU5 | |
| LYYKKDKRRHETHRH | 696 | Q8NFZ3 | |
| RLVKLHIKRHYHKKF | 6 | Q14435 | |
| HKRYKIQKKVREHHR | 16 | Q9BVP2 | |
| KVYTKSSHLKAHRRT | 326 | Q9Y4X4 | |
| EHLEKHRKDKAHKRY | 141 | P82914 | |
| NHKRKKLRFHEVTFH | 1291 | Q9HCM1 | |
| DARYKLHHHLHKTLR | 301 | Q8WW24 | |
| VKGHHVRIYERLKHR | 2916 | P08F94 | |
| FTYKRTVHEWKRKHH | 291 | Q5T5J6 | |
| KRHRPQHYKHEDAKE | 56 | Q7Z3I7 | |
| VYHTKKKTHHSRLVD | 976 | Q15468 | |
| KHFSALRKHKIIHTG | 771 | A8MXY4 | |
| KFHFIRHEKNHTRKK | 171 | Q5T5D7 | |
| HKLYLKKHERIHTGE | 531 | Q6PDB4 | |
| LTRHKRIHTGEKRYK | 476 | Q5SXM1 | |
| KLYTTAHHLKVHERS | 246 | P52747 | |
| FTRKTHLRIHYKNKH | 1181 | Q13129 | |
| RSDHLTKHYKTHLVT | 596 | Q02086 | |
| RDRHIKLHTGDKKYH | 161 | Q96K83 | |
| FSRKSHLKRHRIIHT | 856 | Q8N4W9 | |
| RFTSLKEHIKYRHEK | 181 | P37275 | |
| LTSHKRIHTGEKRYK | 216 | Q03938 | |
| TYHQLVLHSRVHKKD | 386 | O75362 | |
| KTSLRYHLERHHKEK | 511 | O75362 | |
| RREHVKRHSLVHKKD | 761 | Q96DT7 | |
| RDRHIKLHTGDKKYH | 181 | Q2M1K9 | |
| LKIHERIHTGEKRYH | 1081 | Q8NAP3 | |
| KRLTSLKEHIKYRHE | 221 | O60315 | |
| FKYKHHLKEHLRIHS | 291 | O60315 | |
| KYHLERHKRVHSGEK | 141 | Q8NDX6 | |
| TLTKHKRIHTRGKHY | 116 | Q15940 | |
| GHKYTLIKHQRIHTE | 326 | P52741 | |
| HFSALRKHKIIHTGK | 331 | A6NN14 | |
| FKHFSALRKHKVIHT | 581 | A6NN14 | |
| KHFSALRKHKVIHTG | 1086 | A6NN14 | |
| FRYSLHLNKHLRKHV | 341 | Q8NC26 | |
| HLTKHKRIHTREKAY | 386 | Q9Y2Q1 | |
| LTTHKRIHTGEKRYK | 216 | O75373 |